市場調査報告書：心臓核医学

Abstract

The purpose of this report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to diagnose and monitor heart diseases. This study also discusses key products in nuclear cardiology and examines the trends that are stimulating this market. It includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The main objectives of this analysis are to:

Identify viable technology drivers through a comprehensive look at platform technologies for nuclear cardiology testing.
Obtain a complete understanding of the individual nuclear cardiology testing platforms from their basic principles to their clinical applications.
Discover feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas.
Focus on global industry developments through an in-depth analysis of the major world markets for nuclear cardiology technology, including growth forecasts.
Present market figures related to the current value of nuclear cardiology, market projections, market share, key players, and sector growth rates.

An analysis of the nuclear cardiology market must include several key areas of related activity. The most important segments discussed in this report include:

Hardware (e.g., nuclear cardiology instrumentation).
Software (e.g., nuclear cardiology image processing, PACS).
Radiopharmaceuticals and pharmaceuticals.
Ancillary products.
Service and support.

1. Overview

1.1 Objectives
1.2 Scope
1.3 Methodology
1.4 Executive Summary

2. Medical Imaging Market Analysis

2.1 Medical Imaging Industry Market Size
2.2 Medical Imaging Infrastructure
- 2.2.1 Total Healthcare Expenditures and Demographics
- 2.2.2 Number of Hospitals
- 2.2.3 Number of Radiologists
- 2.2.4 Radiology Services
- 2.2.5 Medical Imaging Companies
- 2.2.6 Market Drivers
  - 2.2.6.1 Product Enhancements
  - 2.2.6.2 Contrast Agents Development
  - 2.2.6.3 Innovation
- 2.2.7 Market Restraints
- 2.2.8 Market Segments for Medical Imaging
  - 2.2.8.1 Discovery
  - 2.2.8.2 Clinical Applications
  - 2.2.8.3 Clinical Trials
  - 2.2.8.4 Outpatient Facilities
  - 2.2.8.5 Technology Advances in Diagnostic Imaging Modalities
  - 2.2.8.6 Safety and Ergonomics Concerns
  - 2.2.8.7 Volumetric Imaging
  - 2.2.8.8 Digital Radiography (DR)
  - 2.2.8.9 Contrast Media

3. Nuclear Medicine and Nuclear Cardiology Market

3.1 Medical Imaging Industry Forecasts
3.2 Hardware Companies (Nuclear Medicine Instrumentation)
3.3 Software Companies (Image Processing and PACS)
3.4 Radiopharmaceuticals and Pharmaceuticals Companies
3.5 Ancillary Products Companies
3.6 Service and Support Companies
3.7 Nuclear Cardiology Market
3.8 Hardware (PET, SPECT and Hybrids)
- 3.8.1 Scanner Investment: Not Just a Cardiology Market
  - 3.8.1.1 Impact of Alzheimer' s Reimbursement
- 3.8.2 Sales Trends for PET Scanners
- 3.8.3 Market Consolidation in the U.S.
- 3.8.4 Learning Curve Impact for PET
- 3.8.5 Hardware Market Trends
3.9 Software (PACS and RIS)
3.10 Radiopharmaceuticals
- 3.10.1 Diagnostic Radiopharmaceuticals
- 3.10.2 Therapeutic Radiopharmaceuticals

4. Products Analysis

4.1 Nuclear Medicine Instrumentation
- 4.1.1 PET Scan
- 4.1.2 SPECT Scan
  - 4.1.2.1 Heart Imaging
- 4.1.3 PET Versus SPECT
- 4.1.4 Hybrid Technology
4.2 Image Processing: PACS
- 4.2.1 PACS and Nuclear Medicine
- 4.2.2 Difficulties in Making PACS Work with Nuclear Medicine
  - 4.2.1.2 3-D and Quantitative Analysis
  - 4.2.1.5 Small Market Opportunities
4.3 Radiopharmaceuticals and Pharmaceuticals
- 4.3.1 Introduction
- 4.3.2 Background
- 4.3.3 Areas of Current Interest

5. Regulations, Reimbursements and Other Issues

5.1 Food and Drug Administration (FDA)
- 5.1.1 FDA Guidance
- 5.1.2 FDA Nuclear Medicine Coalition
5.2 U.S. Nuclear Regulatory Commission (NRC)
- 5.2.1 What NRC Regulates
- 5.2.2 How NRC Regulates
- 5.2.3 Related Information
5.3 Memorandum of Understanding between NRC and FDA
- 5.3.1 Authorities and Regulatory Programs
5.4 Current NRC Issues and Actions
- 5.4.1 Meetings
- 5.4.2 Program and Policy Issues
- 5.4.3 Recently Issued Significant Enforcement Actions
  - 5.4.3.1 Stark II Regulations
  - 5.4.3.2 Recent Impact of Stark II Regulations
  - 5.4.3.3 Reimbursement

6. Business Affairs (Mergers, Acquisitions and Partnerships)

6.1 Recent Corporate Partnerships and Mergers
6.2 Recent Industry Activity
6.3 Product Launches and Developments

7. Technology Trends

7.1 Hardware (Nuclear Medicine Instrumentation)
7.2 Software (PACS)
- 7.2.1 Problems Interfacing PACS and NM
- 7.2.2 SNM and IHE
- 7.2.3 IHE Nuclear Medicine Profile
- 7.2.4 What Next?
- 7.2.5 Optimal Patient Care
- 7.2.6 Four Steps to Standards Adoption
- 7.2.7 Technical Framework: Business with Technology
- 7.2.8 Leading by Example
- 7.2.9 IHE and Electronic Health Record (EHR)
7.3 Radiopharmaceuticals and Pharmaceuticals
- 7.3.1 Market Share
- 7.3.2 Contrast Media Market Drivers
- 7.3.3 Contrast Media Market Sector Overview
- 7.3.4 Contrast Media Market Analysis
- 7.3.5 Growth Prospects for Contrast Media
7.4 Market Sector Analysis
7.5 Leading Companies in General Medical Imaging

8. Company Profiles

8.1 Hardware (Nuclear Medicine Instrumentation)
- 8.1.1 AccuSync Medical Research
- 8.1.2 Bristol-Myers Squibb (Medical Imaging)
- 8.1.3 Capintec
- 8.1.4 CardiArc
- 8.1.5 Cardinal Health (Cardiology Solutions)
- 8.1.6 Digirad
- 8.1.7 GE Healthcare
- 8.1.8 GVI Medical Devices
- 8.1.9 Hitachi Medical Systems America
- 8.1.10 IS2 Medical Systems
- 8.1.11 Mediso
- 8.1.12 Philips Medical
- 8.1.13 Positron
- 8.1.14 Siemens Medical
- 8.1.15 Spectrum Dynamics
8.2 Software (Image Processing and PACS)
- 8.2.1 Heartlab
- 8.2.2 Hermes Medical Solutions
- 8.2.3 INVIA
- 8.2.4 McKesson
- 8.2.5 MedImage
- 8.2.6 MIMvista
- 8.2.7 Numa
- 8.2.8 ProSolv Cardiovascular
- 8.2.9 Scientific Imaging
- 8.2.10 Segami Corporation
- 8.2.11 Syntermed
- 8.2.12 Thinking Systems Corporation
- 8.2.13 UltraSPECT
- 8.2.14 Witt Biomedical Corporation
8.3 Radiopharmaceuticals and Pharmaceuticals
- 8.3.1 Astellas Pharma U.S.
- 8.3.2 Bracco Diagnostics
- 8.3.3 Isotope Products Laboratories
- 8.3.4 Izotop: Institute of Isotopes
- 8.3.5 Mallinckrodt
- 8.3.6 Merck
- 8.3.7 NuView Radiopharmaceuticals
- 8.3.8 Pfizer
- 8.3.9 Tyco Healthcare
8.4 Ancillary Products
- 8.4.1 CNMTStore.com
- 8.4.2 Data Spectrum Corporation
- 8.4.3 Daxor Corporation
- 8.4.4 Ivy Biomedical Systems
- 8.4.5 MarCal Medical
8.5 Service and Support
- 8.5.1 BC Technical
- 8.5.2 Diagnostix Plus
- 8.5.3 MedAxiom
- 8.5.4 MediNuclear Corporation (MNC)
- 8.5.5 MEDX
- 8.5.6 Pinestar Technology
- 8.5.7 Technology Imaging Services
8.6 Other Business Opportunities

9. Other Elements of Nuclear Medicine Industry

9.1 Nuclear Medicine: Guidelines, Certification and Societies
- 9.1.1 American College of Radiology (ACR)
- 9.1.2 American Society of Nuclear Cardiology (ASNC)
- 9.1.3 Associates in Medical Physics (AMP)
- 9.1.4 Certification Board of Nuclear Cardiology (CBNC)
- 9.1.5 ICANL
- 9.1.6 IHE
- 9.1.7 ISO
- 9.1.8 MedPage Today
- 9.1.9 Nuclear Medicine Technology Certification Board (NMTCB)
- 9.1.10 Society of Cardiovascular Computed Tomography (SCCT)
- 9.1.11 Society of Nuclear Medicine (SNM)
9.2 Nuclear Medicine: Publications
- 9.2.1 Elsevier
- 9.2.2 HRA Research
- 9.2.3 Lippincott Williams & Wilkins

INDEX OF FIGURES

Figure 3.1: U.S. Nuclear Imaging Procedures
Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006
Figure 4.1: Nuclear Imaging
Figure 4.2: PET Scan
Figure 4.3: SPECT Scan
Figure 4.4: PET-CT Scan
Figure 4.5: SPECT-CT Scan
Figure 7.1: IHE Technical Framework
Figure 7.2: IHE Framework Organization
Figure 7.3: IHE Actors and Transactions

INDEX OF TABLES

Table 2.1: U.S. Medical Imaging Market Size, 2001-2010
Table 2.2: Global Medical Imaging Market Size, 2001-2010
Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010
Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products
Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050
Table 2.6: Hospital Survey
Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004
Table 2.8: Worldwide Market Share of Medical Imaging Companies
Table 2.9: Worldwide Imaging Procedures, 2001 to 2010
Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities
Table 7.1: Market Share of Contrast Media Players
Table 7.2: Contrast Media Market Growth, 2003-2010
Table 7.3: Worldwide Imaging Procedures, 2001-2010
Table 8.1: Astellas Alliances

心臓核医学市場

Nuclear Cardiology Markets

Abstract

Table of Contents

1. Overview

2. Medical Imaging Market Analysis

3. Nuclear Medicine and Nuclear Cardiology Market

4. Products Analysis

5. Regulations, Reimbursements and Other Issues

6. Business Affairs (Mergers, Acquisitions and Partnerships)

7. Technology Trends

8. Company Profiles

9. Other Elements of Nuclear Medicine Industry

INDEX OF FIGURES

INDEX OF TABLES